Viviane Klingmann
- Pharmaceutical Science top 2%
-
- Pharmaceutical studies and practices 21
- Pediatric Pain Management Techniques 5
- Family Practice top 10%
- Medication Adherence and Compliance 3
- Speech and Hearing top 5%
- Psychiatry and Mental health top 10%
- Child Nutrition and Feeding Issues 7
- Attention Deficit Hyperactivity Disorder 2
-
- Pharmaceutical Economics and Policy 6
-
- Child and Adolescent Health 4
-
- Cystic Fibrosis Research Advances 4
- Co-authors
- Jörg BreitkreutzThomas MeißnerHans Martin BosseChristian LerchAndreas MoeltnerCornelia FrömkeErtan MayatepekManfred Wargenau
- Journals
- The Journal of Pediatrics (3 papers)Archives of Disease in Childhood (2 papers)European Journal of Pharmaceutics and Biopharmaceutics (4 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Viviane Klingmann
19 papers receiving 679 citations
Peers
Comparison fields: 5 of 82
- Pharmaceutical Science 163
- Pediatrics, Perinatology and Child Health 504
- Family Practice 26
- Speech and Hearing 78
- Psychiatry and Mental health 131
Countries citing papers authored by Viviane Klingmann
This map shows the geographic impact of Viviane Klingmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viviane Klingmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viviane Klingmann more than expected).
Fields of papers citing papers by Viviane Klingmann
This network shows the impact of papers produced by Viviane Klingmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viviane Klingmann. The network helps show where Viviane Klingmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Viviane Klingmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 2 | |
| 11 | 2022 | 11 | |
| 12 | 2021 | 10 | |
| 13 | 2021 | 25 | |
| 14 | 2020 | 48 | |
| 15 | 2018 | 50 | |
| 16 | 2018 | 79 | |
| 17 | 2016 | 30 | |
| 18 | 2015 | 111 | |
| 19 | 2013 | 159 | |
| 20 | 2012 | 134 |
About Viviane Klingmann
Viviane Klingmann is a scholar working on Family Practice, Pediatrics, Perinatology and Child Health and Applied Microbiology and Biotechnology, having authored 21 papers that have together received 698 indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (21 papers), Child Nutrition and Feeding Issues (7 papers), Pharmaceutical Economics and Policy (6 papers), Pediatric Pain Management Techniques (5 papers), Child and Adolescent Health (4 papers), Cystic Fibrosis Research Advances (4 papers), Medication Adherence and Compliance (3 papers) and Attention Deficit Hyperactivity Disorder (2 papers). The work is most often cited by research in Pharmaceutical Science (163 citations), Pediatrics, Perinatology and Child Health (504 citations) and Family Practice (26 citations). Viviane Klingmann has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Jörg Breitkreutz, Thomas Meißner, Hans Martin Bosse, Christian Lerch, Andreas Moeltner, Cornelia Frömke, Ertan Mayatepek, Manfred Wargenau, Andreas Möltner and Ingrid Klingmann. Their work appears in journals such as The Journal of Pediatrics, Archives of Disease in Childhood and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.